In the News

Organoids Touted as Future of Brain Disorder R&D as AxoSim Scoops Up Tech from Vyant Subsidiary

As Vyant Bio continues its wind-down, the neuroscience research assets of its subsidiary StemoniX have officially been picked up by AxoSim, a New Orleans-based drug discovery biotech.

October 24, 2023
Loading the Elevenlabs Text to Speech AudioNative Player...

Related Stories

Spotlight
2/5/2026
Organoid Intelligence Offers New Evidence of Learning-related Activity in Human Neural Tissue
Human-derived neural networks can exhibit measurable markers of learning and memory processes.
In the News
7/17/2023
AxoSim Enters Into a Definitive Agreement to Acquire Vyant Bio's StemoniX Assets
AxoSim has entered a definitive agreement to acquire Vyant Bio's StemoniX microBrain™ platform, uniting top-tier organoid technologies to accelerate neurological drug discovery.
In the News
2/28/2024
AxoSim Appoints Two Biotech Industry Veterans as Co-Chairs of Its Board of Directors
Serial Entrepreneurs Dale Pfost and David Weiner Bring Broad Expertise as AxoSim Expands Its Leadership in Human Organoid Technologies Designed to Make Neurological R&D Faster, More Efficient and More Successful.
Join our mailing list.
Thank you! Your submission has been received.
Something went wrong while submitting the form.
© 2025 28bio. All rights reserved.
Privacy Policy
Terms of Use
FCOI Polcy